CYBN Latest Headlines

Helus Pharma Rebrands, Moves to Nasdaq as It Advances Late-Stage Mental Health Drugs

at www.tipranks.com (Mon, 5-Jan 8:19 AM)

Cybin Launches $100 Million At-The-Market Equity Program to Fuel Mental Health Drug Innovation

Market Chameleon (Wed, 31-Dec 8:41 AM)

Cybin Showcases Late-Stage Mental Health Innovations at Jefferies Global Healthcare Conference

Market Chameleon (Wed, 12-Nov 9:42 AM)

Cybin to Spotlight Innovation in Mental Health at Milken Institute Future of Health Summit

Market Chameleon (Mon, 3-Nov 8:26 AM)

Cybin Secures $175 Million in Direct Offering, Accelerates Clinical Pipeline and Clears Debt

Market Chameleon (Tue, 28-Oct 10:38 AM)

Cybin’s $175 Million Registered Direct Offering: Strategic Funding Targets Debt Repayment and Advancing Phase 3 Clinical Trials

Market Chameleon (Tue, 28-Oct 9:05 AM)